Serums & Essences · 19/06/2026
NMN in skincare: the cellular energy molecule that is reshaping the anti-aging serum conversation
NMN began as a longevity supplement and has moved into topical skincare. Understanding what the molecule does at the cellular level explains why the transition to skincare makes biological sense.
What NMN does in cells and why it became a longevity molecule
Nicotinamide mononucleotide (NMN) is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular energy metabolism and a key substrate for sirtuin enzymes that regulate DNA repair, cellular stress responses, and circadian rhythm maintenance. NAD+ levels decline significantly with age — by approximately 50 percent between age 40 and 60 — contributing to reduced cellular energy production, impaired DNA repair capacity, and the downstream consequences that produce many hallmarks of physiological ageing. NMN supplementation replenishes NAD+ levels by providing the precursor the cell uses to synthesise it, and has demonstrated in clinical studies improvements in muscle function, metabolic efficiency and cardiovascular markers associated with NAD+ restoration.
The logic of topical NMN: NAD+ in skin fibroblasts and keratinocytes
Skin fibroblasts and keratinocytes both rely on NAD+ for their energy metabolism and sirtuin-mediated functions — collagen synthesis by fibroblasts, for example, is an energy-intensive process that declines with NAD+ availability. Topical NMN applied to skin can be absorbed by keratinocytes in the epidermis, where it is converted to NAD+ and contributes to cellular energy availability for the DNA repair and barrier maintenance functions that keratinocytes perform. The extent to which topical NMN reaches the dermis and contributes to fibroblast function is less clearly established — molecular weight and skin permeability limitations affect dermal delivery — but epidermis-level NAD+ restoration has functional consequences for skin surface quality that are independent of the dermal collagen question.
The Numbuzin No.9 NMN and multi-active approach
Numbuzin's No.9 formula combines NMN with glutathione, peptides and hyaluronic acid — applying the multi-mechanism anti-aging philosophy at the serum level. NMN addresses cellular energy and sirtuin-mediated repair; glutathione provides antioxidant activity and its independently documented brightening effect through melanin inhibition; peptides signal fibroblast activity for collagen synthesis; HA provides immediate plumping hydration that makes improvements visible immediately before the longer-term mechanisms of NMN and peptide action accumulate. The combination is designed to produce both immediate and longer-term visible improvement, addressing the marketing reality that users need to see results quickly while the more meaningful structural improvements take months to manifest.
NMN versus other anti-aging approaches at the cellular energy level
NMN represents a different category of anti-aging active than the cell-signalling approaches of retinoids (retinoic acid receptor activation), copper peptides (matrix metalloproteinase modulation), or vitamin C (collagen hydroxylation enzyme support). NMN addresses the energy substrate availability for cellular processes rather than signalling any specific process to increase. This means it is complementary to rather than competing with other anti-aging actives — a formula that combines NMN with peptides is not redundant because NMN provides the energetic substrate that the peptide-stimulated collagen synthesis will require. The combination produces better outcomes than either alone because the signalling and the energy availability are addressed simultaneously.
The evidence status for topical NMN: emerging but consistent
Topical NMN skincare is a genuinely emerging category — the substantial clinical evidence for oral NMN supplementation does not automatically transfer to topical application, and the topical-specific studies are fewer and more recent than for established actives like retinoids or vitamin C. What exists: in vitro studies confirming keratinocyte uptake and NAD+ elevation from NMN application; manufacturer clinical studies showing improvements in skin texture, firmness and luminosity metrics over 4 to 8 weeks of consistent use; and the mechanistic plausibility from the oral supplementation literature. The honest position is that topical NMN shows consistent early evidence for meaningful skin improvement, is mechanistically well-supported, and warrants the consumer interest it is receiving — while the definitive long-form clinical evidence is still being established.